The presently observed downregulation of CFTR expression in human fibrotic kidneys and the suppression of kidney fibrosis progression in UUO mice upon forced CFTR overexpression indicate the possibility of using CFTR as a new or combined treatment target along with TGF-β in the fibrotic kidney diseases, which warrants future investigations. Here, TGFB1 is linked to kidney disorder.